Caterna | Updates

By Jana Frömke

A Long Way to Caterna – The Experiences of a Norwegian Mother


Dear Companist,

Today, we would like to share a very special story that we have recently received with you: It is about a young patient in Norway whose mother finally found a way to help her son through the Caterna Vision Training after a long search on the Internet.


First contact: Patient inquiry

As early as June, we received a request from a Norwegian mother.* She herself has Turkish roots, was born in Germany, and now lives in Norway with her husband and children. She was desperate because her 9-year-old son' vision was only 50%. A bilateral refraction amblyopia was discovered too late. Her son had severe reading and writing problems at school, could not concentrate, and was considered a child with learning difficulties.

The mother herself reports that it is often the parents who are desperate because their child has problems - the child does not even notice it or often only compares itself negatively with others. After a long search on the Internet, the mother found Caterna's German website and wanted to know whether Caterna could help her son.


A long search in several countries

The doctors and clinics in Norway had said that their son had to live with 50% visual acuity, as the development of vision was already complete at his age. The parents refused to settle for this. During a stay in Turkey, a Turkish doctor finally recommended that they apply an eye patch. They then decided to alternate occluding both eyes on a weekly basis.

When the mother asked Norwegian parents and orthoptists about Caterna after her online research, she came across another hurdle: They did not want to prescribe Caterna because the program was unknown to them. Encouraged by the many health insurance companies that provide Caterna Vision Training in Germany, she looked online for another way to use the therapy. She found an optometrist who already had experience with other web-based vision training and was more open to Caterna. In contrast to the doctors, he recommended simply trying out the program. After Caterna had contacted this optometrist and sent him informational material, he determined the necessary visual acuity and ordered the prescription.


Great results already after a few weeks of therapy

Already after one month of therapy, an ophthalmological check-up showed significant improvements. The teachers at school also noticed a change in reading and praised the son for his improving performance. As soon as the first therapy is finished, the parents will probably start another one to stabilize the result and draw the attention of people around them to Caterna. "Please distribute this game all over the world," she writes, "there are so many children who need it. The price is definitely very reasonable considering the result and all children should benefit."

Stories like those of this mother encourage us every day that we are on the right path. The personal experiences of our patients and the accompanying orthoptists show us repeatedly that the therapy can also help children with whom previous attempts failed. We would like to shorten their "Odyssey" from doctor to doctor and the tedious Internet-search with our current advertising measures, SEO optimizations, and the digitalization of prescriptions - so that children playfully learn to see better even faster!


Best greetings,

Jana Frömke

* We have anonymized the story because it concerns a child's health data.


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 188,800


€ 576

Average Investment

10.59 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Caterna.
Already registered?    Log in